16399213|t|Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
16399213|a|To determine whether apolipoprotein alleles (APOE) influence behavioral and psychological signs and symptoms of dementia (BPSD), we initiated a prospective, longitudinal study. Patients with Alzheimer's disease (AD) (N=186), frontotemporal dementia (FTD) (N=29), mixed dementia (MXD) (N=28), dementia with Lewy bodies (DLB) (N=11) and Parkinson's disease dementia (PDD) (N=7) were included. Blood was collected for DNA extraction and APOE genotyping. Behavioral assessments were performed at baseline and semi-annually thereafter, using behavioral assessment scales (Middelheim frontality score, behavioral pathology in Alzheimer's disease rating scale (Behave-AD)). In FTD patients, we identified dose dependent effects of APOE epsilon4 on the Behave-AD total and cluster aggressiveness scores. APOE epsilon2 was associated with a higher score on the Behave-AD cluster delusions in PDD/DLB patients. No APOE effects on frequency or severity of BPSD in AD and MXD patients were found. In conclusion, APOE has disease-specific effects on BPSD in FTD and PDD/DLB patients, given the reported associations of APOE epsilon4 with aggression (FTD) and of APOE epsilon2 with delusions (PDD/DLB).
16399213	25	29	APOE	Gene	348
16399213	65	86	frontal lobe dementia	Disease	MESH:D003704
16399213	133	137	APOE	Gene	348
16399213	200	208	dementia	Disease	MESH:D003704
16399213	210	214	BPSD	Disease	
16399213	265	273	Patients	Species	9606
16399213	279	298	Alzheimer's disease	Disease	MESH:D000544
16399213	300	302	AD	Disease	MESH:D000544
16399213	313	336	frontotemporal dementia	Disease	MESH:D057180
16399213	338	341	FTD	Disease	MESH:D057180
16399213	351	365	mixed dementia	Disease	MESH:D000093902
16399213	367	370	MXD	Disease	MESH:D000093902
16399213	380	405	dementia with Lewy bodies	Disease	MESH:D020961
16399213	407	410	DLB	Disease	MESH:D020961
16399213	423	451	Parkinson's disease dementia	Disease	MESH:D010300
16399213	453	456	PDD	Disease	MESH:D010300
16399213	522	526	APOE	Gene	348
16399213	708	727	Alzheimer's disease	Disease	MESH:D000544
16399213	749	751	AD	Disease	MESH:D000544
16399213	758	761	FTD	Disease	MESH:D057180
16399213	762	770	patients	Species	9606
16399213	812	816	APOE	Gene	348
16399213	840	842	AD	Disease	MESH:D000544
16399213	861	875	aggressiveness	Disease	MESH:D010554
16399213	940	957	Behave-AD cluster	Disease	MESH:D000544
16399213	958	967	delusions	Disease	MESH:D063726
16399213	971	974	PDD	Disease	MESH:D010300
16399213	975	978	DLB	Disease	MESH:D020961
16399213	979	987	patients	Species	9606
16399213	992	996	APOE	Gene	348
16399213	1033	1037	BPSD	Disease	
16399213	1041	1043	AD	Disease	MESH:D000544
16399213	1048	1051	MXD	Disease	MESH:D000093902
16399213	1052	1060	patients	Species	9606
16399213	1088	1092	APOE	Gene	348
16399213	1125	1129	BPSD	Disease	
16399213	1133	1136	FTD	Disease	MESH:D057180
16399213	1141	1144	PDD	Disease	MESH:D010300
16399213	1145	1148	DLB	Disease	MESH:D020961
16399213	1149	1157	patients	Species	9606
16399213	1194	1198	APOE	Gene	348
16399213	1213	1223	aggression	Disease	MESH:D010554
16399213	1225	1228	FTD	Disease	MESH:D057180
16399213	1256	1265	delusions	Disease	MESH:D063726
16399213	1267	1270	PDD	Disease	MESH:D010300
16399213	1271	1274	DLB	Disease	MESH:D020961
16399213	Association	MESH:D020961	348
16399213	Association	MESH:D003704	348
16399213	Association	MESH:D010300	348
16399213	Association	MESH:D010554	348
16399213	Association	MESH:D057180	348

